PRIME THERAPEUTICS for PRIME THERAPEUTICS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education on the value of biosimilars; H.R. 19/S. 2164: "Lower Cost, More Cures Act," provisions on drug prices and Part D cost-sharing and Part D reform. H.R. 5376/P.L. 117-169: "Build Back Better Act"/"Inflation Reduction Act," provisions relating to insulin cost-sharing; repeal of the rebate rule. S. 3700/H.R. 6833: "Affordable Insulin Now Act," provisions related to cost-sharing for insulin in Medicare and private plans. Draft versions of the "INSULIN Act," provisions on cost-sharing, utilization management and rebates for insulin. S. 4293: "The Pharmacy Benefit Manager Transparency Act of 2022," provisions on the FTC regulation of PBMs. S. 1388: "Prescription Pricing for the People Act of 2021," provisions related to an FTC study of PBMs; provisions related to restrictions on spread pricing in the commercial market for PBMs. H.R. 7666: "The Restoring Hope for Mental Health and Well-Being Act of 2022," Title VI, Sec. 602, Oversight of Pharmacy Benefit Manager Services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG | — |
Medicare/Medicaid MMM
Final Rule, Department of Health and Human Services: Office of Inspector General, issued November 20, 2020 entitled "Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Services Fees." Outreach on pharmacy direct and indirect remuneration in Medicare Part D and CMS-4192-P, Proposed and Final Rules, Medicare Program: Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Program. H.R. 19/S. 2164: "Lower Cost, More Cures Act," provisions on drug prices and Part D cost-sharing and Part D reform. H.R. 5376/P.L. 117-169: "Inflation Reduction Act"/"Build Back Better Act," provisions relating to insulin cost-sharing; Medicaid and Medicare drug pricing; Medicare Part D reform, repeal of the rebate rule. S. 3700/H.R. 6833: "Affordable Insulin Now Act," provisions related to cost-sharing for insulin in Medicare and private plans and mental health issues as they relate to prescription drug plans. Draft versions of the "INSULIN Act," provisions on cost-sharing, utilization management and rebates for insulin. H.R. 8487: "Seniors Timely Access to Care Act," general education on prior authorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.